SLAYBACK PHARMA INDIA Profile Photo

SLAYBACK PHARMA INDIA

(AZURITY PHARMACEUTICALS INDIA LLP)

4 Published Patents

Hyderabad

Founded in 2017

About SLAYBACK PHARMA INDIA

Slayback Pharma is a specialty pharmaceutical startup that specializes in the development, manufacturing, and sourcing of complex generic pharmaceutical products, particularly complex injectables and other non-solid oral products. Through strategic product selection, execution, and collaboration with contract R&D laboratories and manufacturing organizations, Slayback has curated a unique portfolio of complex generics. They possess advanced capabilities in rapid development, sophisticated manufacturing, and innovative drug delivery technologies.

Key Founders and Directors of SLAYBACK PHARMA INDIA

Key Focus Areas of SLAYBACK PHARMA INDIA

Biopharma +2 more focus areas

Angel Networks & VC Investors of SLAYBACK PHARMA INDIA

+1 more fund

Frequently Asked Questions (FAQ)

Where is SLAYBACK PHARMA INDIA's headquarters?

SLAYBACK PHARMA INDIA is based out of Hyderabad.

When was SLAYBACK PHARMA INDIA founded?

SLAYBACK PHARMA INDIA was founded in the year 2017.

What is the legal name of SLAYBACK PHARMA INDIA?

The legal name of SLAYBACK PHARMA INDIA is Azurity Pharmaceuticals India Llp.

Who are the founders of SLAYBACK PHARMA INDIA?

SLAYBACK PHARMA INDIA is founded by Sateesh Parise and Singh Gyan Ranjan.

Which VC Investors & Angel Networks funded SLAYBACK PHARMA INDIA?

SLAYBACK PHARMA INDIA is funded by VC Investors & Angel Networks like Everstone and 1 other.

What are the focus areas of SLAYBACK PHARMA INDIA?

The key focus areas of SLAYBACK PHARMA INDIA are Biopharma and 2 others.

Who are SLAYBACK PHARMA INDIA's competitors?

Possible competitors of SLAYBACK PHARMA INDIA may include Aura Biotechnologies, Bransun Labs Llp, Endhiram Innovations Llp and 7 others.

Get Access to Complete Information

Signup Now

YNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits